Vijaya Diagnostic Centre’s board has approved the amalgamation of Medinova Diagnostic Services. Effective November 4, 2025, Medinova will dissolve, and its assets and liabilities will transfer to Vijaya. The share exchange ratio is 22:1. Medinova Millennium MRI Services LLP becomes a wholly-owned subsidiary. The board also approved an increase in the authorized share capital.
Amalgamation Approval
The Board of Directors at Vijaya Diagnostic Centre has approved the amalgamation of Medinova Diagnostic Services Limited, effective November 04, 2025. The decision was made during a board meeting held on the same date.
Key Details of the Amalgamation
The effective date of the scheme is Tuesday, November 04, 2025. Upon the effectiveness of the scheme, Medinova Diagnostic Services Limited will be dissolved. The directors, key managerial personnel, and statutory auditors of Medinova Diagnostic Services Limited will vacate their positions, effective November 04, 2025.
Share Exchange Ratio
The share exchange ratio for the amalgamation is set at 22:1. For every 22 equity shares held in Medinova, shareholders will receive 1 equity share in Vijaya Diagnostic Centre.
Subsidiary Update
Following the amalgamation, Medinova Millennium MRI Services LLP will become a wholly-owned subsidiary of Vijaya Diagnostic Centre, effective November 04, 2025.
Capital Amendment
The Authorised Share Capital of the Company stands increased to INR 230,500,000 divided into 230,500,000 Equity Shares of face value of INR 1 each.
Investment Cancellation
The investment of 62,02,220 equity shares in Medinova Diagnostic Services Limited will be cancelled.
Medinova Millennium MRI Services LLP Details
Medinova Millennium MRI Services LLP is a wholly-owned subsidiary with operations in Kolkata, West Bengal. It was incorporated on November 21, 2014. The total obligatory contribution is ₹ 500,000,000, and the actual contribution received is ₹ 230,270,000. Last three years’ turnover: FY 2024-25 – ₹ 2.36 Crores, FY 2023-24 – ₹ 2.49 Crores, FY 2022-23 – ₹ 2.27 Crores.
Source: BSE
